InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,214.08
(
0.51%
)
US TECH 100
17,655.56
(
0.30%
)
Dow Jones
39,387.76
(
0.85%
)
Brent Oil
83.95
(
0.47%
)
Bitcoin
62,843.56
(
2.71%
)
Post# of 1620
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

123414

Send PM Follow Ignore
Followers 21
Posts 1996
Boards Moderated 0
Alias Born 11/26/2014

123414

Re: 123414 post# 1537

Sunday, 04/03/2022 4:15:29 PM

Sunday, April 03, 2022 4:15:29 PM

Post# of 1620
The comp hit 67% CR at 18/24months on one dose ph 1

FDA issued BTD AA Priority review from that data.

Then the first 12 patients were undertreated.

Now full dose data is becoming dominant in study
and in the NMIBC Nonresponse market.

JMO, maybe, maybe not.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent IBRX News
More IBRX News
InvestorsHub NewsWire

VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM

Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM

Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM

Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM

Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM

Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM

Start posting your company's news
Only $200 per official company press release!